Daily infusion of a total parenteral nutrition (TPN) formulation containing 1 liter of 5.5% Travasol provides less than 0.1 milligrams of iron. By comparison, a formulation which includes a liter of 10% Travamin provides 2 milligrams of iron per day. To meet iron requirements in patients infusing formulations containing Travasol, iron was added as ferrous citrate. In in vitro experiments, 74% of this iron was available to transferrin. In seven patients in whom in vivo availability was tested by red cell incorporation, the mean availability was 81%. Ferrous citrate is recommended as a safe, effective additive to TPN solutions for adult patients requiring iron supplements.
|Original language||English (US)|
|Number of pages||4|
|Journal||Journal of Parenteral and Enteral Nutrition|
|State||Published - Mar 1983|
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Nutrition and Dietetics